We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Graham Corp
GHM
$1.31B
| $172K | ﹤0.01% |
13,438
-3,279
| -20% | -$43K |
|
2727
IDEAYA Biosciences
IDYA
$3.56B
| $172K | ﹤0.01% |
13,670
+324
| +2% | +$4.01K |
|
2728
Pulse Biosciences
PLSE
$3.02B
| $172K | ﹤0.01% |
14,552
-2,360
| -14% | -$25.4K |
|
2729
Ardmore Shipping
ASC
$683M
| $171K | ﹤0.01% |
47,945
-6,935
| -13% | -$27.1K |
|
|
HBMD
2730
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $171K | ﹤0.01% |
19,010
-2,834
| -13% | -$27.5K |
|
|
BF
2731
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $171K | ﹤0.01% |
+11,173
| New | +$171K |
|
|
CSTR
2732
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $170K | ﹤0.01% |
17,366
-5,390
| -24% | -$56.9K |
|
2733
First Business Financial Services
FBIZ
$595M
| $168K | ﹤0.01% |
11,750
-1,728
| -13% | -$26.8K |
|
2734
Lifetime Brands
LCUT
$211M
| $168K | ﹤0.01% |
17,780
-2,498
| -12% | -$21.5K |
|
2735
LSI Industries
LYTS
$924M
| $168K | ﹤0.01% |
24,848
-5,475
| -18% | -$35.4K |
|
2736
Parke Bancorp
PKBK
$405M
| $168K | ﹤0.01% |
14,080
-2,253
| -14% | -$28.2K |
|
|
PLYM
2737
DELISTED
Plymouth Industrial REIT
PLYM
| $168K | ﹤0.01% |
13,648
-2,353
| -15% | -$30.7K |
|
2738
Apyx Medical
APYX
$171M
| $167K | ﹤0.01% |
35,373
-8,254
| -19% | -$40.9K |
|
|
RRD
2739
DELISTED
RR Donnelley & Sons Co.
RRD
| $166K | ﹤0.01% |
113,503
+1,825
| +2% | +$2.32K |
|
|
WBK
2740
DELISTED
Westpac Banking Corporation
WBK
| $166K | ﹤0.01% |
13,768
+2,910
| +27% | +$36.1K |
|
|
SLCT
2741
DELISTED
Select Bancorp, Inc.
SLCT
| $164K | ﹤0.01% |
22,823
-3,416
| -13% | -$26K |
|
2742
Spero Therapeutics
SPRO
$73M
| $163K | ﹤0.01% |
14,648
-3,281
| -18% | -$38.8K |
|
|
CBIO
2743
Crescent Biopharma
CBIO
$626M
| $162K | ﹤0.01% |
528
-61
| -10% | -$23.3K |
|
2744
Paysign
PAYS
$705M
| $162K | ﹤0.01% |
28,595
-4,503
| -14% | -$35.1K |
|
|
BOCH
2745
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $162K | ﹤0.01% |
23,183
-3,399
| -13% | -$25.1K |
|
|
EVFM
2746
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $161K | ﹤0.01% |
4,538
+65
| +1% | +$2.83K |
|
2747
Corbus Pharmaceuticals
CRBP
$190M
| $160K | ﹤0.01% |
2,964
-431
| -13% | -$78.1K |
|
|
SFE
2748
DELISTED
Safeguard Scientifics, Inc.
SFE
| $160K | ﹤0.01% |
29,169
-4,170
| -13% | -$24.9K |
|
2749
NextCure
NXTC
$26.7M
| $159K | ﹤0.01% |
1,509
-242
| -14% | -$29.8K |
|
|
ESXB
2750
DELISTED
Community Bankers Trust Corporation
ESXB
| $158K | ﹤0.01% |
31,085
-4,651
| -13% | -$23.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.